GlassScriptPhysician profile
Christina Seo
NPI 1730384686
$5,009.67
in general payments reported to CMS, 2019-2025
19 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,253 · 2020: $13.58 · 2021: $20.46 · 2022: $33.24 · 2023: $3,227 · 2024: $159 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,563 · Food and Beverage: $1,110 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,562.54 |
| Food and Beverage | $1,110.24 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,961.03 | 2023 | Da Vinci Surgical System |
| Covidien LP | $600.00 | 2019 | |
| Sirtex Medical INC | $145.38 | 2023 | Sir-Spheres Microspheres |
| Guard Medical INC. | $144.39 | 2025 | Npseal |
| Olympus America INC. | $136.77 | 2019 | |
| Amgen INC. | $130.83 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Sanara Medtech INC. | $124.80 | 2024 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $120.29 | 2023 | Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.61 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $107.48 | 2019 | |
| Abbott Laboratories | $100.15 | 2019 | |
| Merck Sharp & Dohme LLC | $55.79 | 2019-2020 | |
| Integra Lifesciences Corporation | $33.24 | 2022 | |
| Thd America, INC. | $28.13 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27.68 | 2025 | Signia |
| Convatec INC. | $19.48 | 2019 | |
| Ethicon US, LLC | $19.30 | 2024 | Enseal, Stratafix |
| Braintree Laboratories, INC. | $15.33 | 2024 | Sutab, Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Seo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.